Skip to main content
NIH funding notice PAR-18-548

Clinical Validation of a Candidate Biomarker for Neurological Disease (U44 - Clinical Trial Optional)

Closed on September 7, 2020.

Posted
December 22, 2017
Close date
September 7, 2020
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

1 competing award (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $699,413 in first-year total cost, median $699,413.

Most frequent study sections

  1. Neurological Sciences and Disorders A Study Section[NSD-A]1

Most frequent institutions

  1. NEURAL ANALYTICS, INC.1
Competing awards under PAR-18-548 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2020Prehospital Diagnostic Biomarker for Large Vessel Occlusion1U44NS109952-01A1HAMILTON, ROBERTNEURAL ANALYTICS, INC., CA$699,413NSD

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.